GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sihuan Pharmaceutical Holdings Group Ltd (FRA:TEL1) » Definitions » Change In Other Working Capital

Sihuan Pharmaceutical Holdings Group (FRA:TEL1) Change In Other Working Capital : €-2.1 Mil (TTM As of Jun. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Sihuan Pharmaceutical Holdings Group Change In Other Working Capital?

Sihuan Pharmaceutical Holdings Group's Change In Other Working Capital for the quarter that ended in Jun. 2024 was €-4.0 Mil. It means Sihuan Pharmaceutical Holdings Group's Other Working Capital declined by €4.0 Mil from Dec. 2023 to Jun. 2024 .

Sihuan Pharmaceutical Holdings Group's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was €-24.7 Mil. It means Sihuan Pharmaceutical Holdings Group's Other Working Capital declined by €24.7 Mil from Dec. 2022 to Dec. 2023 .


Sihuan Pharmaceutical Holdings Group Change In Other Working Capital Historical Data

The historical data trend for Sihuan Pharmaceutical Holdings Group's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sihuan Pharmaceutical Holdings Group Change In Other Working Capital Chart

Sihuan Pharmaceutical Holdings Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Other Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.03 -9.45 31.34 50.03 -24.71

Sihuan Pharmaceutical Holdings Group Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 55.67 -3.31 -26.69 1.89 -4.03

Sihuan Pharmaceutical Holdings Group Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-2.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sihuan Pharmaceutical Holdings Group Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Sihuan Pharmaceutical Holdings Group's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Sihuan Pharmaceutical Holdings Group Business Description

Traded in Other Exchanges
Address
Zhubang 2000, 22nd Floor, Building 4, West Balizhuang, Chaoyang District, Beijing, CHN, 100025
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Respiratory, Neurology, and others. The group has three reportable segments: the medical aesthetic products segment including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others; the innovative medicine and other medicine segments; and the generic medicine segment which generates key revenue. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the United States.

Sihuan Pharmaceutical Holdings Group Headlines

No Headlines